Cressman, S., Karsan, A., Hogge, D., McPherson, E., Bolbocean, C., Regier, D., & Peacock, S. (2016). Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia. Wiley.
Citazione stile Chigago Style (17a edizione)Cressman, S., A. Karsan, DE Hogge, E. McPherson, C. Bolbocean, DA Regier, e SJ Peacock. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.
Citatione MLA (9a ed.)Cressman, S., et al. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.